National Research (NASDAQ:NRC) Releases Quarterly Earnings Results, Meets Expectations

National Research (NASDAQ:NRC) released its quarterly earnings results on Tuesday. The company reported $0.21 EPS for the quarter, hitting the consensus estimate of $0.21, FiscalAI reports. The firm had revenue of $38.40 million for the quarter, compared to analyst estimates of $35.80 million. National Research had a return on equity of 164.26% and a net margin of 4.18%.

National Research Stock Down 3.1%

Shares of National Research stock traded down $0.70 during trading hours on Tuesday, hitting $21.75. 105,711 shares of the company’s stock traded hands, compared to its average volume of 111,171. National Research has a twelve month low of $11.43 and a twelve month high of $23.68. The company has a market cap of $494.73 million, a PE ratio of 87.00 and a beta of 0.25. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 13.13. The stock has a 50 day simple moving average of $21.12 and a 200-day simple moving average of $19.13.

Analyst Upgrades and Downgrades

Several analysts have issued reports on NRC shares. Citizens Jmp increased their price objective on shares of National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 29th. Zacks Research upgraded shares of National Research to a “hold” rating in a research note on Monday, October 5th. Weiss Ratings cut shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, October 9th. Finally, Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $26.00.

National Research Company Profile

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.

Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.